Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1994 | 1 |
2004 | 1 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
The following terms were not found in PubMed: achondroplasia-developmental, delay-acanthosis
Page 1
Rabson-Mendenhall Syndrome in a brother-sister pair in Kuwait: Diagnosis and 5 year follow up.
Prim Care Diabetes. 2021 Feb;15(1):175-177. doi: 10.1016/j.pcd.2020.07.012. Epub 2020 Aug 23.
Prim Care Diabetes. 2021.
PMID: 32843252
AIM: To report on Rabson-Mendenhall Syndrome (RMS) diagnosed in Kuwait. METHODS: A toddler (18 months old) was referred with high plasma insulin and dysmorphic features suggestive of RMS including coarse facial features with globular nose, full lips and furrowed tongue. .. …
AIM: To report on Rabson-Mendenhall Syndrome (RMS) diagnosed in Kuwait. METHODS: A toddler (18 months old) was referred with high pla …
Clinical profiles, occurrence, and management of adolescent patients with HAIR-AN syndrome.
Omar HA, Logsdon S, Richards J.
Omar HA, et al.
ScientificWorldJournal. 2004 Jul 8;4:507-11. doi: 10.1100/tsw.2004.106.
ScientificWorldJournal. 2004.
PMID: 15258677
Free PMC article.
The syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) is a subphenotype of the polycystic ovary syndrome. ...Of the patients, 80% were compliant with the follow-up and treatment regimen, 60% maintained or reduced their weigh …
The syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) is a subphenotype of the polycystic o …
Item in Clipboard
Response of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) and IGFBP-3 to IGF-I treatment in severe insulin resistance.
Quin JD, Checkley A, Gallagher A, Jones J, MacCuish AC, Miell JP.
Quin JD, et al.
J Endocrinol. 1994 Apr;141(1):177-82. doi: 10.1677/joe.0.1410177.
J Endocrinol. 1994.
PMID: 7516962
It has been suggested that recombinant human IGF-I (rhIGF-I) is a potential therapeutic agent in diabetes mellitus. It is known to have glucose-lowering effects in normal individuals, in patients with non-insulin-dependent diabetes (NIDDM) and in extreme insulin-resistant …
It has been suggested that recombinant human IGF-I (rhIGF-I) is a potential therapeutic agent in diabetes mellitus. It is known to ha …
Item in Clipboard
Cite
Cite